SCHEMBL26427010

SCHEMBL26427010

C1=Cc2sc3cc4ncccc4cc3c2C=CN=1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.34
▸ CASP1 P29466 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ CASP7 P55210 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ PDGFRB P09619 1/20 0.33
▸ PDGFRA P16234 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ CASP6 P55212 1/20 0.32
▸ HTT P42858 2/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ NR4A2 P43354 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ HSP90AA1 P07900 1/20 0.31
▸ HSP90AB1 P08238 1/20 0.31
▸ MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26427014 0.95 ALDH1A1 (0.34) ALDH1A1CASP1MEN1CASP7KMT2A
SCHEMBL26427013 0.76 HASPIN (0.33) —
SCHEMBL26427011 0.76 HASPIN (0.33) —
SCHEMBL26423542 0.66 GPR3 (0.47) ALDH1A1CASP1MEN1CASP7KMT2A
SCHEMBL26423607 0.66 LMNA (0.43) ALDH1A1CASP1MEN1CASP7KMT2A
SCHEMBL26423589 0.66 NPC1 (0.42) ALDH1A1CASP1MEN1CASP7KMT2A
SCHEMBL753445 0.65 NPC1 (0.47) ALDH1A1CASP1MEN1CASP7KMT2A
SCHEMBL25549501 0.64 CASP6 (0.45) ALDH1A1CASP1MEN1CASP7KMT2A
SCHEMBL18719391 0.64 NPC1 (0.46) ALDH1A1CASP1MEN1CASP7KMT2A
SCHEMBL18719388 0.64 NPC1 (0.42) ALDH1A1CASP1MEN1CASP7KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-04-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL OCIAD2, OCIAD1, AZI2 ALDH1A1 302/4885CASP1 1530/4885MEN1 4289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback